Claus Johansen

Department of Dermatology, Aarhus University Hospital

Affiliated withAarhus University Hospital

Research Area

Biography

Claus Johansen has not added Biography.
If you are Claus Johansen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 28	2017

Other Publications

Article	Year
Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1alpha,25-dihydroxyvitamin D3-induced differentiation. Archives of dermatological research\| PubMed ID: 12920533	2003
1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. Archives of dermatological research\| PubMed ID: 15372276	2004
Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16424170	2006
Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. The Journal of investigative dermatology\| PubMed ID: 16543895	2006
IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms. The Journal of investigative dermatology\| PubMed ID: 17255956	2007
Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. The Journal of investigative dermatology\| PubMed ID: 17429437	2007
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect. The Journal of investigative dermatology\| PubMed ID: 17495961	2007
The activity of caspase-1 is increased in lesional psoriatic epidermis. The Journal of investigative dermatology\| PubMed ID: 17597823	2007
Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases. Experimental dermatology\| PubMed ID: 18081851	2008
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice. The Journal of investigative dermatology\| PubMed ID: 18987672	2009
Inflammasomes and inflammatory caspases in skin inflammation. Expert review of molecular diagnostics\| PubMed ID: 18999922	2008
The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice. The EMBO journal\| PubMed ID: 19590497	2009
MK2 regulates the early stages of skin tumor promotion. Carcinogenesis\| PubMed ID: 19808857	2009
The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA. PloS one\| PubMed ID: 20072629	2010
The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice. Experimental dermatology\| PubMed ID: 21166721	2011
Caspase-5 expression is upregulated in lesional psoriatic skin. The Journal of investigative dermatology\| PubMed ID: 21191419	2011
Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model. Cancer investigation\| PubMed ID: 21314333	2011
Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate. Acta dermato-venereologica\| PubMed ID: 21336470	2011
Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines--a possible link between reduced skin barrier function and inflammation? Experimental dermatology\| PubMed ID: 21539619	2011
Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB. The Journal of biological chemistry\| PubMed ID: 21628458	2011
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Experimental dermatology\| PubMed ID: 21707761	2011
CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways. Cytokine\| PubMed ID: 21993219	2011
Inflammation-induced alterations in the skin barrier function: implications in atopic dermatitis. Chemical immunology and allergy\| PubMed ID: 22433374	2012
IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab. Acta dermato-venereologica\| PubMed ID: 22930279	2013
TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK. Experimental dermatology\| PubMed ID: 23800059	2013
Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models. BMC immunology\| PubMed ID: 24245569	2013
Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin. Experimental dermatology\| PubMed ID: 24628979	2014
Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis. International journal of dermatology\| PubMed ID: 24962808	2014
A Characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis. Dermatology reports\| PubMed ID: 25386251	2010
Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK. PloS one\| PubMed ID: 26295581	2015
IκBζ is a key driver in the development of psoriasis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 26460049	2015
IκBζ: A key protein in the pathogenesis of psoriasis. Cytokine\| PubMed ID: 26615569	2016
Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results. SpringerPlus\| PubMed ID: 26788445	2016
Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules. Molecular and cellular therapies\| PubMed ID: 26819710	2016
Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ. The Journal of investigative dermatology\| PubMed ID: 27117051	2016
Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes. Experimental dermatology\| PubMed ID: 27488462	2017
IL-17F regulates psoriasis-associated genes through IκBζ. Experimental dermatology\| PubMed ID: 27576147	2017
The "Alarmins" HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth. Acta dermato-venereologica\| PubMed ID: 27868148	2017
TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model. Experimental dermatology\| PubMed ID: 27943421	2017
Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α. PloS one\| PubMed ID: 28005985	2016
Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment. Experimental dermatology\| PubMed ID: 28109175	2017
STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes. PloS one\| PubMed ID: 28472186	2017
Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study. Blood\| PubMed ID: 29208599	2017